ONCOLOGY ONE Trademark

Trademark Overview


On Thursday, March 17, 2022, a trademark application was filed for ONCOLOGY ONE with the United States Patent and Trademark Office. The USPTO has given the ONCOLOGY ONE trademark a serial number of 79339082. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 5, 2023. This trademark is owned by Oncology One Pty Ltd. The ONCOLOGY ONE trademark is filed in the Pharmaceutical Products category with the following description:

Biochemicals for pharmaceutical use for the treatment, prevention or diagnosis of cancer or diseases or disorders associated with cancer; chemicals for pharmaceutical use for the treatment of cancer or diseases or disorders associated with cancer; chemical preparations for medical purposes, namely, for cancer treatment, and prevention or diagnosis or the treatment of cancer, and prevention or diagnosis of diseases or disorders associated with cancer; chemical preparations for pharmaceutical purposes, namely, for cancer treatment, prevention or diagnosis or the treatment of cancer, and prevention or diagnosis of diseases or disorders associated with cancer; pharmaceutical preparations for the treatment of cancer and diseases and disorders associated with cancer; pharmaceutical products for the treatment of cancer and diseases and disorders associated with cancer
oncology one

General Information


Serial Number79339082
Word MarkONCOLOGY ONE
Filing DateThursday, March 17, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, December 5, 2023
Registration Number0000000
Registration DateTuesday, February 20, 2024
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 5, 2023

Trademark Statements


Description of MarkThe mark consists of two concentric unclosed circles around a closed circle design with the wording "ONCOLOGYONE" below.
Goods and ServicesBiochemicals for pharmaceutical use for the treatment, prevention or diagnosis of cancer or diseases or disorders associated with cancer; chemicals for pharmaceutical use for the treatment of cancer or diseases or disorders associated with cancer; chemical preparations for medical purposes, namely, for cancer treatment, and prevention or diagnosis or the treatment of cancer, and prevention or diagnosis of diseases or disorders associated with cancer; chemical preparations for pharmaceutical purposes, namely, for cancer treatment, prevention or diagnosis or the treatment of cancer, and prevention or diagnosis of diseases or disorders associated with cancer; pharmaceutical preparations for the treatment of cancer and diseases and disorders associated with cancer; pharmaceutical products for the treatment of cancer and diseases and disorders associated with cancer
Pseudo MarkO ONCOLOGYONE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes052, 051, 005, 018, 006, 044, 046
Class Status Code6 - Active
Class Status DateFriday, April 29, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOncology One Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Party NameOncology One Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type82 - NOT AVAILABLE
AddressAU

Trademark Events


Event DateEvent Description
Tuesday, February 20, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 5, 2023PUBLISHED FOR OPPOSITION
Sunday, December 3, 2023NOTIFICATION PROCESSED BY IB
Wednesday, November 15, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 15, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 30, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 30, 2023EXAMINER'S AMENDMENT ENTERED
Monday, October 30, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 30, 2023EXAMINERS AMENDMENT E-MAILED
Monday, October 30, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, October 23, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, October 4, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 4, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, September 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 19, 2023REFUSAL PROCESSED BY IB
Wednesday, March 29, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, March 28, 2023REFUSAL PROCESSED BY MPU
Wednesday, February 1, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, January 31, 2023NON-FINAL ACTION WRITTEN
Thursday, December 29, 2022ASSIGNED TO EXAMINER
Tuesday, May 3, 2022APPLICATION FILING RECEIPT MAILED
Friday, April 29, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 28, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB